Structural Determinants of Phenotypic Diversity and Replication Rate of Human Prions

English version České info

Sporadic Creutzfeldt-Jakob disease (sCJD) represents ~90% of all human prion diseases worldwide. This neurodegenerative disease, which is transmissible and invariably fatal, is characterized by variable progression rates and remarkable diversity of clinical and pathological traits. The infectious sCJD prions propagating the pathology mainly in the brain are assemblies of abnormally folded isoform (PrPSc) of a host-encoded prion protein (PrPC). The structure and replication mechanisms of human prions are unknown, and whether the PrPSc subtypes identified by proteolytic fragmentation represent distinct strains of sCJD prions has been debated. Here, we isolated sCJD prions from patients with two very distant phenotypes of the disease, compared their structural organization using recently developed biophysical techniques, and investigated their replication in vitro. Our data indicate that these sCJD prions are characterized by different secondary structure organization and quaternary packing arrangements, and that these structural differences are responsible for distinct prion replication rates and unique phenotypic characteristics of the disease. Furthermore, our analysis reveals that, contrary to previous observations for yeast prions, the replication tempo of sCJD prions is determined not so much by their conformational stability but by specific structural features that control the growth speed of prion particles.

Vyšlo v časopise: Structural Determinants of Phenotypic Diversity and Replication Rate of Human Prions. PLoS Pathog 11(4): e32767. doi:10.1371/journal.ppat.1004832
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004832

Souhrn

Zdroje

1. Prusiner SB, Scott MR, DeArmond SJ, Carlson G (2004) Transmission and replication of prions. In: Prusiner SB, editor. Prion Biology and Diseases. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. pp. 187–242.

2. Gajdusek DC, Gibbs CJ Jr., Alpers M (1966) Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209: 794–796. 5922150

3. Gibbs CJ Jr., Gajdusek DC, Asher DM, Alpers MP, Beck E, et al. (1968) Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161: 388–389. 5661299

4. Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, et al. (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11: 618–628. doi: 10.1016/S1474-4422(12)70063-7 22710755

5. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66: 213–239. 14522861

6. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, et al. (2005) Diagnosis of human prion disease. Proc Natl Acad Sci USA 102: 3501–3506. 15741275

7. Safar JG (2012) Molecular Mechanisms Encoding Quantitative and Qualitative Traits of Prion Strains. In: Gambetti P, editor. Prions and Diseases. New York: Springer Verlag.

8. Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 107: 12005–12010. doi: 10.1073/pnas.1004688107 20547859

9. Giles K, Glidden DV, Patel S, Korth C, Groth D, et al. (2010) Human prion strain selection in transgenic mice. Ann Neurol 68: 151–161. doi: 10.1002/ana.22104 20695008

10. Wadsworth JD, Joiner S, Linehan JM, Desbruslais M, Fox K, et al. (2008) Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A 105: 3885–3890. doi: 10.1073/pnas.0800190105 18316717

11. Legname G, Nguyen H-OB, Peretz D, Cohen FE, DeArmond SJ, et al. (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 103: 19105–19110. 17142317

12. Colby DW, Giles K, Legname G, Wille H, Baskakov IV, et al. (2009) Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A 106: 20417–20422. doi: 10.1073/pnas.0910350106 19915150

13. Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, et al. (2012) Small Protease Sensitive Oligomers of PrP(Sc) in Distinct Human Prions Determine Conversion Rate of PrP(C). PLoS Pathog 8: e1002835. doi: 10.1371/journal.ppat.1002835 22876179

14. Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, et al. (2011) Protease-Sensitive Conformers in Broad Spectrum of Distinct PrP Structures in Sporadic Creutzfeldt-Jakob Disease Are Indicator of Progression Rate. PLoS Pathog 7: e1002242. doi: 10.1371/journal.ppat.1002242 21931554

15. Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, et al. (2008) Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 4: e1000029. doi: 10.1371/journal.ppat.1000029 18389084

16. Wadsworth JD, Collinge J (2011) Molecular pathology of human prion disease. Acta Neuropathol 121: 69–77. doi: 10.1007/s00401-010-0735-5 20694796

17. Gambetti P, Cali I, Notari S, Kong Q, Zou WQ, et al. (2011) Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol 121: 79–90. doi: 10.1007/s00401-010-0761-3 21058033

18. Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, et al. (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4: 805–814. 16297838

19. Haldiman T, Kim C, Cohen Y, Chen W, Blevins J, et al. (2013) Coexistence of Distinct Prion Types Enables Conformational Evolution of Human PrPSc by Competitive Selection. J Biol Chem 288: 29846–29861. doi: 10.1074/jbc.M113.500108 23974118

20. Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, et al. (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132: 2643–2658. doi: 10.1093/brain/awp196 19734292

21. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr. (1993) Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 268: 20276–20284. 8104185

22. Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, et al. (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124: 517–529. doi: 10.1007/s00401-012-1002-8 22744790

23. Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B, et al. (2011) Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol 18: 504–506. doi: 10.1038/nsmb.2035 21441913

24. Cobb NJ, Apostol MI, Chen S, Smirnovas V, Surewicz WK (2014) Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region. J Biol Chem 289: 2643–2650. doi: 10.1074/jbc.M113.520718 24338015

25. Del Mar C, Greenbaum EA, Mayne L, Englander SW, Woods VL Jr. (2005) Structure and properties of alpha-synuclein and other amyloids determined at the amino acid level. Proc Natl Acad Sci U S A 102: 15477–15482. 16223878

26. Lu X, Wintrode PL, Surewicz WK (2007) Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci U S A 104: 1510–1515. 17242357

27. Smirnovas V, Kim JI, Lu X, Atarashi R, Caughey B, et al. (2009) Distinct Structures of Scrapie Prion Protein (PrPSc)-seeded Versus Spontaneous Recombinant Prion Protein Fibrils Revealed by Hydrogen/Deuterium Exchange. J Biol Chem 284: 24233–24241. doi: 10.1074/jbc.M109.036558 19596861

28. Toyama BH, Kelly MJ, Gross JD, Weissman JS (2007) The structural basis of yeast prion strain variants. Nature 449: 233–237. 17767153

29. Toyama BH, Weissman JS (2011) Amyloid structure: conformational diversity and consequences. Annu Rev Biochem 80: 557–585. doi: 10.1146/annurev-biochem-090908-120656 21456964

30. Miller MB, Wang DW, Wang F, Noble GP, Ma J, et al. (2013) Cofactor molecules induce structural transformation during infectious prion formation. Structure 21: 2061–2068. doi: 10.1016/j.str.2013.08.025 24120764

31. Cobb NJ, Sonnichsen FD, McHaourab H, Surewicz WK (2007) Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci U S A 104: 18946–18951. 18025469

32. Groveman BR, Dolan MA, Taubner LM, Kraus A, Wickner RB, et al. (2014) Parallel in-register intermolecular beta-sheet architectures for prion-seeded prion protein (PrP) amyloids. J Biol Chem 289: 24129–24142. doi: 10.1074/jbc.M114.578344 25028516

33. Govaerts C, Wille H, Prusiner SB, Cohen FE (2004) Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A 101: 8342–8347. 15155909

34. Miyagi M, Nakazawa T (2008) Determination of pK(a) values of individual histidine residues in proteins using mass spectrometry. Anal Chem 80: 6481–6487. doi: 10.1021/ac8009643 18665614

35. Miyagi M, Wan Q, Ahmad MF, Gokulrangan G, Tomechko SE, et al. (2011) Histidine Hydrogen-Deuterium Exchange Mass Spectrometry for Probing the Microenvironment of Histidine Residues in Dihydrofolate Reductase. PLoS One 6.

36. Tran DT, Banerjee S, Alayash AI, Crumbliss AL, Fitzgerald MC (2012) Slow histidine H/D exchange protocol for thermodynamic analysis of protein folding and stability using mass spectrometry. Anal Chem 84: 1653–1660. doi: 10.1021/ac202927p 22185579

37. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, et al. (2005) Structure of the cross-beta spine of amyloid-like fibrils. Nature 435: 773–778. 15944695

38. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, et al. (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447: 453–457. 17468747

39. Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442: 585–589. 16810177

40. Uptain SM, Lindquist S (2002) Prions as protein-based genetic elements. Annu Rev Microbiol 56: 703–741. 12142498

41. Bett C, Joshi-Barr S, Lucero M, Trejo M, Liberski P, et al. (2012) Biochemical properties of highly neuroinvasive prion strains. PLoS Pathog 8: e1002522. doi: 10.1371/journal.ppat.1002522 22319450

42. Peretz D, Scott M, Groth D, Williamson A, Burton D, et al. (2001) Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 10: 854–863. 11274476

43. Ayers JI, Schutt CR, Shikiya RA, Aguzzi A, Kincaid AE, et al. (2011) The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog 7: e1001317. doi: 10.1371/journal.ppat.1001317 21437239

44. World Health Organization (1999) WHO infection control guidelines for transmissible spongiform encephalopathies. Geneva. 38 p.

45. Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL (2008) Rapidly progressive dementia. Ann Neurol 64: 97–108. doi: 10.1002/ana.21430 18668637

46. Zanusso G, Liu D, Ferrari S, Hegyi I, Yin X, et al. (1998) Prion protein expression in different species: Analysis with a panel of new mAbs. Proc Natl Acad Sci USA 95: 8812–8816. 9671761

47. Safar J, Wille H, Itri V, Groth D, Serban H, et al. (1998) Eight prion strains have PrPSc molecules with different conformations. Nat Med 4: 1157–1165. 9771749

48. Morillas M, Swietnicki W, Gambetti P, Surewicz WK (1999) Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 274: 36859–36865. 10601237

49. Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, et al. (2008) Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5: 211–212. doi: 10.1038/nmeth0308-211 18309304

50. Castilla J, Morales R, Saa P, Barria M, Gambetti P, et al. (2008) Cell-free propagation of prion strains. EMBO J 27: 2557–2566. doi: 10.1038/emboj.2008.181 18800058

51. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, et al. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83: 79–90. 7553876

52. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, et al. (1997) Typing prion isoforms. Nature 386: 232–233. 9069279

53. Langeveld JP, Jacobs JG, Erkens JH, Bossers A, van Zijderveld FG, et al. (2006) Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep. BMC Vet Res 2: 19. 16764717

54. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, et al. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61: 3688–3693. 2446004

55. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, et al. (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270: 19173–19180. 7642585